Furthermore, multiple studies have shown that abnormal test results lost to follow up (i.e. missed results) occur in diverse settings (e.g., academic, private, VA, hospital, and ambulatory settings), involve a variety of staff types (e.g., trainees, staff physicians, and mid-level providers), and across multiple types of diagnostic studies [ 1- 4, 11, 47].
In addition to the difficulties noted above (diverse protocols, subject selection, and lack of multiple doses in diagnostic studies), other factors may affect the threshold values observed in a clinical trial, including concomitant exercise or other stresses, other diseases, age, the presence of seasonal pollen allergies, pharmaceutical treatments, etc.
In this article nonparametric simultaneous confidence intervals for multiple AUC's in diagnostic studies are presented.
Several studies utilize multiple diagnostic models.
Strengths of this study are that to the best of our knowledge this is the first study to validate multiple diagnostic strategies for ruling out pulmonary embolism in the primary care setting.
Given that multiple diagnostic hospitals were involved in the study, in addition to the lack of standardization in the recording of medical chart information for research purposes, misclassifications when analyzing the medical chart data are likely.
In our study, the combination of multiple diagnostic methodologies was used as reference standard because we consider it reliable.
Because of multiple diagnostic misunderstandings that may arise from the individual parameters forming the study protocol, the system of "score" with PI-RADS was introduced.
Studies on metastasis-promoting genes, which are the preferred targets for diagnostic studies, are complicated by the requirement for coordinated expression of multiple genes.
One previous study evaluated the distribution of AIP subtypes worldwide, however multiple diagnostic criteria were used based on the country of origin.
